AI and Repurposed Drugs Revolutionize Food Allergy Research at Summit
The Food Allergy Fund Summit in New York City showcased significant advancements in food allergy research, emphasizing the role of artificial intelligence (AI) and repurposed drugs. AI technology, developed by Anjo.ai, demonstrated the ability to detect anaphylactic reactions in real-time using smartwatch data, potentially improving safety for individuals with food allergies. Additionally, the Summit highlighted the progress of repurposing FDA-approved drugs, such as zileuton, abrocitinib, and metformin, for food allergy treatment. These drugs, with established safety profiles, can expedite the transition to human trials. The event also introduced a caregiver resource developed with Dr. Becky Kennedy, aimed at supporting families managing food allergies. 
